Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. Castellino SM, Pei Q, Parsons SK, Hodgson D, et al. N Engl J Med 2022;387:1649-1660.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Castellino SM, Pei Q, Parsons SK, Hodgson D, et al. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. N Engl J Med 2022;387:1649-1660.
PMID: 36322844